$JNJ

AI 分析

生成於 May 11, 2026

AI Score
71/ 100
Hold$JNJ

Johnson & Johnson

$JNJNYSEHealthcareMega-Cap

J&J is a diversified healthcare company with businesses in pharmaceuticals (Innovative Medicine) and medical devices (MedTech).

Market Cap
$360.0B
Revenue (TTM)
$85.2B
+5.0%
Net Income (TTM)
$14.3B
+8.0%
EPS (TTM)
$5.90
P/E Ratio
16.5
Dividend Yield
3.0%
52-Week Range
$140-$168
Beta
0.52
Dimension Scores
Fundamental
73
Technical
62
Sentiment
68
Risk / Reward
78
Momentum
58
FundTechSentRiskMome
Financial Health
Profitability
78strong
Growth
61moderate
Liquidity
86strong
Solvency
75strong
Efficiency
71strong

Valuation, technical analysis, investment thesis, risk assessment and more for $JNJ

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。